For surface numbing, benzocaine and lidocaine perform about equally well, and head-to-head clinical trials consistently bear that out. The real differences between them show up in safety profiles, how many ways each drug can be used, and which regulatory warnings apply. Lidocaine is the more versatile of the two, available in topical, injectable, and even intravenous forms, while benzocaine is almost exclusively a topical agent found in over-the-counter gels, sprays, and lozenges. That versatility, combined with a cleaner safety record, is why many clinicians default to lidocaine when either drug could work.
How the Two Drugs Differ Under the Hood
Benzocaine and lidocaine both block sodium channels in nerve cells, which is how all local anesthetics stop pain signals from reaching your brain. But they belong to different chemical families, and that distinction matters more than it might sound. Benzocaine is an ester-type anesthetic, while lidocaine is an amide-type. At the body’s normal pH, lidocaine carries a positive electrical charge, which helps it bind tightly to sodium channels in nerves that are actively firing. Benzocaine, by contrast, stays electrically neutral, so it interacts with those channels differently and doesn’t produce the same kind of use-dependent nerve block that lidocaine does.1PubMed Central. Using Lidocaine and Benzocaine to Link Sodium Channel Molecular Conformations to State-Dependent Antiarrhythmic Drug Affinity
In practical terms, this means lidocaine is better suited for situations where deeper or longer-lasting nerve blockade is needed, including injection into tissue. Benzocaine works well on the surface of skin and mucous membranes but doesn’t penetrate deeply enough or last long enough for most procedures that require injected anesthesia. Its ester structure also means the body breaks it down differently: ester anesthetics are metabolized in the blood and tissues by enzymes called esterases, while amide anesthetics like lidocaine are processed in the liver. That liver-based metabolism gives lidocaine a longer duration of action but also means liver disease can affect how quickly the drug clears your system.
Topical Pain Relief in Dental Settings
Dentistry is where these two drugs have been compared most directly, because dentists routinely apply a topical numbing gel before sticking you with the needle for a deeper injection. The question is simple: does one gel make the needle hurt less than the other?
The evidence is remarkably consistent. A randomized trial comparing 2% lidocaine gel and 20% benzocaine gel for topical anesthesia before needle insertion found them equally effective, and both were better than a placebo gel.2PubMed Central. Clinical effectiveness of lidocaine and benzocaine for topical anesthesia Another trial looking specifically at palatal injections, which tend to be the most painful dental injections, reached the same conclusion: no meaningful difference between the two.3Endodontology. Evaluation of efficacy of 2% lidocaine gel and 20% benzocaine gel for topical anesthesia
A trial in schoolchildren measured pain during an inferior alveolar nerve block, comparing topical lidocaine, benzocaine, and a lidocaine-prilocaine cream. Using both behavioral pain scales and children’s self-reported pain faces, the researchers found no statistically significant difference among the three groups.4PubMed Central. Efficacy of topical anesthetics of lidocaine, benzocaine, and EMLA in reducing pain during inferior alveolar nerve block in schoolchildren: a randomized controlled trial
One trial did break from the pack. A randomized controlled study comparing 2% lignocaine gel (lignocaine is just the international name for lidocaine) against 20% benzocaine gel found benzocaine significantly outperformed lidocaine for reducing needle insertion pain. Nearly half the patients in the benzocaine group reported no pain at all, while most in the lidocaine group reported moderate pain.5PubMed Central. Comparative evaluation of the efficacy of two anesthetic gels (2% lignocaine and 20% benzocaine) in reducing pain during administration of local anesthesia – A randomized controlled trial It’s worth noting the concentration difference here: benzocaine at 20% versus lidocaine at just 2%. That tenfold gap in concentration makes comparison tricky and may explain benzocaine’s edge in that particular trial.
The overall picture from dental research is that when concentration differences are accounted for, these drugs trade blows. Neither consistently outperforms the other for surface numbing before an injection.
Beyond the Dentist’s Chair
Both drugs show up in emergency medicine as components of “GI cocktails,” the antacid-plus-anesthetic mixtures given to people with upper abdominal pain or dyspepsia. A randomized trial comparing viscous lidocaine against benzocaine in a GI cocktail found that both groups experienced significant symptom improvement, with no meaningful difference between them at any of the assessment time points.6The Journal of Emergency Medicine. Prospective randomized study of viscous Lidocaine versus Benzocaine in a GI cocktail for dyspepsia If your ER doctor hands you a pink cup of something to drink for stomach pain, either anesthetic ingredient works about the same.
Where the two drugs diverge sharply is in the range of clinical roles they can fill. Lidocaine is used far beyond topical numbing. Emergency physicians use it intravenously for certain types of acute and chronic pain, including visceral pain and kidney stones. Its properties allow it to be administered by injection, infusion, patch, and spray across many medical specialties.7PubMed Central. Lidocaine and pain management in the emergency department: a review article Benzocaine has no injectable form and no intravenous use. If you’re comparing them only as topical pain relievers applied to a surface, they’re close to interchangeable. But lidocaine wins the versatility contest by a wide margin.
The Methemoglobinemia Problem
This is the safety issue that separates benzocaine from lidocaine most dramatically. Methemoglobinemia is a condition where the oxygen-carrying molecule in your red blood cells gets chemically altered so it can no longer release oxygen to your tissues. It can range from mild, causing bluish skin and shortness of breath, to life-threatening. Benzocaine is a well-known trigger.
A ten-year retrospective study of methemoglobinemia cases linked to topical anesthetics found that more than half of the cases involved benzocaine at 20% concentration. About a fifth involved lidocaine at 1-2%, and a smaller fraction involved combination products containing both drugs.8JAMA Internal Medicine. Risk of Topical Anesthetic–Induced Methemoglobinemia: A 10-Year Retrospective Case-Control Study The disproportion matters: benzocaine accounted for the majority of cases even though lidocaine is used far more widely in clinical practice. The chemistry behind this relates to how benzocaine is broken down in the body. Its ester metabolism produces metabolites that oxidize hemoglobin more readily than lidocaine’s amide metabolites do.
This risk is the main reason the FDA singled out benzocaine for regulatory action. In 2011, the agency issued a warning to avoid using any benzocaine-containing products for infant teething, specifically because of methemoglobinemia risk.9Journal of the American Pharmacists Association. What are pharmacists recommending for infant teething treatment? The FDA later strengthened this to a broader warning covering children under two. Despite the warnings, surveys have found that some pharmacists continued to recommend benzocaine teething gels even after the FDA alert, which highlights a gap between regulatory guidance and what actually happens at the pharmacy counter.
For adults using benzocaine products like sore throat sprays or topical gels, the absolute risk of methemoglobinemia is low. But it’s not zero, and certain conditions raise it: people with heart or lung disease, smokers, and anyone taking medications that already affect hemoglobin are more vulnerable. If you’re choosing between a benzocaine throat spray and a lidocaine one for the same purpose, lidocaine carries less of this specific risk.
Lidocaine’s Own Safety Concerns
Lidocaine is not without its hazards, especially when used in higher doses or by injection. Lidocaine toxicity typically manifests as central nervous system symptoms first, including dizziness, ringing in the ears, metallic taste, and confusion. At higher blood levels, it can cause seizures and cardiac arrhythmias. A case report describes a healthy 37-year-old man who developed a toxic reaction after lidocaine was sprayed into his throat before a procedure.10PubMed Central. Lidocaine toxicity Topical overuse, especially on large areas of broken skin or mucous membranes, can push blood levels high enough to cause systemic effects.
The practical lesson is that both drugs demand respect for dosing limits, but the nature of the risk differs. With benzocaine, the signature danger is methemoglobinemia even at standard doses in susceptible individuals. With lidocaine, the main worry is systemic toxicity from too much drug reaching the bloodstream, which is more of a dosing-and-route problem than an inherent chemical quirk. For typical over-the-counter topical use on small areas, serious reactions to either drug are uncommon.
Allergic Reactions
True allergies to local anesthetics are rarer than most people believe, but they do exist, and the ester-versus-amide distinction matters here. Because benzocaine is an ester anesthetic, it gets metabolized into para-aminobenzoic acid (PABA), a compound known to cause contact allergic reactions. Lidocaine, as an amide, follows a different metabolic path and is less likely to produce allergic contact dermatitis.
Data from Denmark’s patch-testing registry found that the prevalence of contact allergy was about 0.5% for benzocaine and ranged from 0.14% to 0.3% for lidocaine over different time periods.11PubMed. Prevalence of benzocaine and lidocaine patch test sensitivity in Denmark: temporal trends and relevance Current clinical relevance was confirmed in only about 10% of those with benzocaine allergy and 5% with lidocaine allergy, meaning most positive patch tests didn’t correspond to real-world allergic problems. Still, if you’ve had a skin reaction to a benzocaine product before, it’s worth mentioning to your doctor. Switching to an amide anesthetic like lidocaine often solves the problem, since cross-reactivity between the two chemical classes is rare.
Premature Ejaculation Treatments
One of the more common over-the-counter uses for both drugs that people don’t always discuss with their doctor is for managing premature ejaculation. Desensitizing sprays, creams, and condoms containing benzocaine or lidocaine are widely sold, and there is legitimate clinical evidence behind them.
A systematic review and meta-analysis of randomized trials found that lidocaine significantly increased intravaginal ejaculatory latency time (IELT, the standard measure in this field) compared to placebo. The pooled increase across two trials was roughly four and a half minutes.12PubMed Central. Topical Anesthetics and Premature Ejaculation: A Systematic Review and Meta-Analysis A separate randomized trial directly compared EMLA cream (a lidocaine-prilocaine mix), lidocaine spray, and benzocaine condoms in men with lifelong premature ejaculation. All three groups saw significant improvement, but lidocaine spray produced the largest increase in IELT, followed by the EMLA cream, with benzocaine condoms coming in third. Side effects were minimal across all groups, and lowest in the condom group.13PubMed. Comparative efficacy of EMLA cream, lidocaine spray, and benzocaine condoms in treating lifelong premature ejaculation: a randomized clinical study
The difference in delivery method complicates the comparison. A spray allows precise dosing and can be applied to specific areas, while a condom provides more uniform but potentially less concentrated coverage. Whether the lidocaine spray’s advantage reflects the drug itself or simply a better delivery system is hard to disentangle from one trial. What is clear is that both drugs work for this purpose, and the choice often comes down to personal preference and practicality.
Combination Products
Rather than choosing one drug over the other, some products use both together, sometimes with a third anesthetic added. A compounded cream containing benzocaine, lidocaine, and tetracaine (called BLT cream) is commonly used in dermatology clinics before cosmetic procedures like laser treatments, microneedling, or injectable fillers. A study of BLT cream found it significantly reduced pain at the first needle stick compared to no anesthetic, and an abrasive-particle version of the cream (designed to improve skin penetration) performed even better.14PubMed Central. Comparative Study of Compounded Anesthetic Benzocaine/Lidocaine/Tetracaine (BLT) Cream with and without Abrasive Particles
The logic behind combining anesthetics is that different drugs block sodium channels through slightly different mechanisms and at different tissue depths. A combination can theoretically provide faster onset and longer duration than any single agent alone. These compounded products are typically mixed by specialty pharmacies and aren’t the same as the single-ingredient gels you’d buy at a drugstore. They also carry a combined safety profile, so the methemoglobinemia risk from benzocaine doesn’t disappear just because lidocaine is also in the mix.
How They Ended Up in Your Medicine Cabinet
Both drugs trace their origins to the search for alternatives to cocaine, which was the first local anesthetic used in medicine but came with obvious problems. Benzocaine was among a wave of ester-type anesthetics synthesized between 1891 and 1930, alongside drugs like tetracaine and procaine (Novocain). Lidocaine came later, part of a second wave of amide-type anesthetics developed between 1898 and 1972.15PubMed. From cocaine to ropivacaine: the history of local anesthetic drugs Lidocaine, first synthesized in 1943, became a landmark because it was the first widely used amide anesthetic, and its lower allergy risk compared to ester drugs helped it become the default local anesthetic in much of clinical medicine. Benzocaine found its niche in over-the-counter products, partly because its poor water solubility (which limits absorption into the bloodstream) made it seem inherently safer for consumer use. The methemoglobinemia issue, though recognized early on, didn’t receive major regulatory attention until decades later.
Choosing Between Them in Practice
For most everyday situations where you’re picking a product off a pharmacy shelf, here’s what the evidence actually supports:
- Sore throat: Both work about equally well for temporary relief. Lidocaine lozenges or sprays avoid the methemoglobinemia risk that benzocaine carries, which is a marginal but real advantage.
- Mouth sores or minor dental pain: Benzocaine gels like Orajel are the most widely available OTC option. Lidocaine-based alternatives exist and work just as well. For adults without risk factors, the safety difference is small.
- Teething pain in infants: Neither. The FDA has specifically warned against benzocaine for children under two. Pediatric guidelines generally recommend non-pharmacological approaches like chilled teething rings.
- Skin procedures: Lidocaine cream or patches are the standard. For more intensive cosmetic procedures, combination creams (BLT) are common under clinical supervision.
- Sunburn or minor skin irritation: Both are found in OTC products. Application to large areas of damaged skin increases absorption risk for either drug, so use sparingly.
If you have a known allergy to ester anesthetics or a history of methemoglobinemia, lidocaine is the clear better choice. If you need something injectable or for deeper nerve blockade, lidocaine is really the only option between the two. And if you’re picking up something for a child, check the label carefully: benzocaine products should not be used in very young children regardless of how they’re marketed.
Environmental Persistence of Benzocaine
An angle that rarely comes up in consumer discussions is what happens to these drugs after they wash off your skin or get flushed. Benzocaine has drawn attention from environmental chemists because of how it behaves in waterways. Research into benzocaine’s transformation in natural water systems and during advanced oxidation treatment processes has found that while some breakdown products are less toxic than the parent compound, several remain highly toxic, particularly those formed during water treatment processes designed to remove contaminants.16Journal of Environmental Chemical Engineering. Theoretical insights into benzocaine transformation in natural waters and AOPs: Implications for environmental and human health risks This is more of a concern for large-scale use, including benzocaine’s widespread application in fish farming as an anesthetic for aquaculture, than for your tube of Orajel. But it’s a reminder that pharmaceutical compounds don’t simply vanish after they’ve done their job on your gums.